Director's Publications

Goedel WC, King MRF, Lurie MN, Galea S, Townsend JP, Galvani AP, Friedman SR, Marshall BDL: Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study. Clin Infect Dis. 2019 May 30; 2019 May 30. PMID: 31143944

Wells CR, Pandey A, Parpia AS, Fitzpatrick MC, Meyers LA, Singer BH, Galvani AP: Ebola vaccination in the Democratic Republic of the Congo. Proc Natl Acad Sci U S A. 2019 May 14; 2019 Apr 29. PMID: 31036657

Pandey A, Fitzpatrick MC, Galvani AP: Metrics and benchmarks for HIV transition - Authors' reply. Lancet HIV. 2019 Mar. PMID: 30846055

Thomson N, Littlejohn M, Strathdee SA, Southby RF, Coghlan B, Rosenfeld JV, Galvani AP: Harnessing synergies at the interface of public health and the security sector. Lancet. 2019 Jan 19. PMID: 30663581

Capewell P, Atkins K, Weir W, Jamonneau V, Camara M, Clucas C, Swar NK, Ngoyi DM, Rotureau B, Garside P, Galvani AP, Bucheton B, MacLeod A: Resolving the apparent transmission paradox of African sleeping sickness. PLoS Biol. 2019 Jan; 2019 Jan 11. PMID: 30633739

Bartsch SM, Asti L, Cox S, Durham DP, Randall S, Hotez PJ, Galvani AP, Lee BY: What is the Value of Different Zika Vaccination Strategies to Prevent and Mitigate Zika Outbreaks. J Infect Dis. 2018 Dec 13; 2018 Dec 13. PMID: 30544164

Bartsch SM, Avelis CM, Asti L, Hertenstein DL, Ndeffo-Mbah M, Galvani A, Lee BY: The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission. PLoS Negl Trop Dis. 2018 Nov; 2018 Nov 5. PMID: 30395603

Galvani AP, Pandey A, Fitzpatrick MC, Medlock J, Gray GE: Defining control of HIV epidemics. Lancet HIV. 2018 Nov; 2018 Oct 9. PMID: 30314745

Marshall BDL, Goedel WC, King MRF, Singleton A, Durham DP, Chan PA, Townsend JP, Galvani AP: Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study. Lancet HIV. 2018 Sep; 2018 Jun 13. PMID: 29908917

Fitzpatrick MC, Gray GE, Galvani AP: The Challenge of Vanquishing HIV for the Next Generation-Facing the Future. JAMA Pediatr. 2018 Jul 1. PMID: 29800028

Medley GF, Blok DJ, Crump RE, Hollingsworth TD, Galvani AP, Ndeffo-Mbah ML, Porco TC, Richardus JH: Policy Lessons From Quantitative Modeling of Leprosy. Clin Infect Dis. 2018 Jun 1. PMID: 29860289

Rock KS, Ndeffo-Mbah ML, Castaño S, Palmer C, Pandey A, Atkins KE, Ndung'u JM, Hollingsworth TD, Galvani A, Bever C, Chitnis N, Keeling MJ: Assessing Strategies Against Gambiense Sleeping Sickness Through Mathematical Modeling. Clin Infect Dis. 2018 Jun 1. PMID: 29860287

Ndeffo-Mbah ML, Vigliotti VS, Skrip LA, Dolan K, Galvani AP: Dynamic Models of Infectious Disease Transmission in Prisons and the General Population. Epidemiol Rev. 2018 Jun 1. PMID: 29566137

Sah P, Medlock J, Fitzpatrick MC, Singer BH, Galvani AP: Optimizing the impact of low-efficacy influenza vaccines. Proc Natl Acad Sci U S A. 2018 May 15; 2018 Apr 30. PMID: 29712866

Durham DP, Fitzpatrick MC, Ndeffo-Mbah ML, Parpia AS, Michael NL, Galvani AP: Evaluating Vaccination Strategies for Zika Virus in the Americas. Ann Intern Med. 2018 May 1; 2018 Apr 3. PMID: 29610863

Grantz KH, Chabaari W, Samuel RK, Gershom B, Blum L, Worden L, Ackley S, Liu F, Lietman TM, Galvani AP, Prajna L, Porco TC: Spatial distribution of leprosy in India: an ecological study. Infect Dis Poverty. 2018 Mar 27; 2018 Mar 27. PMID: 29580296

Lee BY, Bartsch SM, Skrip L, Hertenstein DL, Avelis CM, Ndeffo-Mbah M, Tilchin C, Dumonteil EO, Galvani A: Are the London Declaration's 2020 goals sufficient to control Chagas disease?: Modeling scenarios for the Yucatan Peninsula. PLoS Negl Trop Dis. 2018 Mar; 2018 Mar 19. PMID: 29554086

King CH, Galvani AP: Underestimation of the global burden of schistosomiasis. Lancet. 2018 Jan 27; 2018 Jan 31. PMID: 29413041

Fitzpatrick MC, Singer BH, Hotez PJ, Galvani AP: Saving lives efficiently across sectors: the need for a Congressional cost-effectiveness committee. Lancet. 2017 Nov 25; 2017 Jun 29. PMID: 28669643

Sah P, Fitzpatrick MC, Pandey A, Galvani AP: HIV criminalization exacerbates subpar diagnosis and treatment across the United States: response to the 'Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States'. AIDS. 2017 Nov 13. PMID: 29068837

Galvani AP, Durham DP, Vermund SH, Fitzpatrick MC: California Universal Health Care Bill: an economic stimulus and life-saving proposal. Lancet. 2017 Oct 28; 2017 Sep 17. PMID: 28923467

Galvani AP, Fitzpatrick MC, Vermund SH, Singer BH: Fund global health: Save lives and money. Science. 2017 Jun 9. PMID: 28596330

Skrip LA, Fallah MP, Gaffney SG, Yaari R, Yamin D, Huppert A, Bawo L, Nyenswah T, Galvani AP: Characterizing risk of Ebola transmission based on frequency and type of case-contact exposures. Philos Trans R Soc Lond B Biol Sci. 2017 May 26. PMID: 28396472

Castro LA, Fox SJ, Chen X, Liu K, Bellan SE, Dimitrov NB, Galvani AP, Meyers LA: Assessing real-time Zika risk in the United States. BMC Infect Dis. 2017 May 4; 2017 May 4. PMID: 28468671

Lee BY, Alfaro-Murillo JA, Parpia AS, Asti L, Wedlock PT, Hotez PJ, Galvani AP: The potential economic burden of Zika in the continental United States. PLoS Negl Trop Dis. 2017 Apr; 2017 Apr 27. PMID: 28448488

Brock AR, Ross JV, Greenhalgh S, Durham DP, Galvani A, Parikh S, Esterman A: Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum. Infect Dis Model. 2017 May; 2017 Apr 15. PMID: 29928735

Alsallaq RA, Gurarie D, Ndeffo Mbah M, Galvani A, King C: Quantitative assessment of the impact of partially protective anti-schistosomiasis vaccines. PLoS Negl Trop Dis. 2017 Apr; 2017 Apr 14. PMID: 28410369

Medlock J, Pandey A, Parpia AS, Tang A, Skrip LA, Galvani AP: Effectiveness of UNAIDS targets and HIV vaccination across 127 countries. Proc Natl Acad Sci U S A. 2017 Apr 11; 2017 Mar 20. PMID: 28320938

Ndeffo-Mbah ML, Galvani AP: Global elimination of lymphatic filariasis. Lancet Infect Dis. 2017 Apr; 2016 Dec 22. PMID: 28012944

Blok DJ, Crump RE, Sundaresh R, Ndeffo-Mbah M, Galvani AP, Porco TC, de Vlas SJ, Medley GF, Richardus JH: Forecasting the new case detection rate of leprosy in four states of Brazil: A comparison of modelling approaches. Epidemics. 2017 Mar. PMID: 28279460

Bartsch SM, Peterson JK, Hertenstein DL, Skrip L, Ndeffo-Mbah M, Galvani AP, Dobson AP, Lee BY: Comparison and validation of two computational models of Chagas disease: A thirty year perspective from Venezuela. Epidemics. 2017 Mar. PMID: 28279459

Fallah MP, Skrip LA, Raftery P, Kullie M, Borbor W, Laney AS, Blackley DJ, Christie A, Dokubo EK, Lo TQ, Coulter S, Baller A, Vonhm BT, Bemah P, Lomax S, Yeiah A, Wapoe-Sackie Y, Mann J, Clement P, Davies-Wayne G, Hamblion E, Wolfe C, Williams D, Gasasira A, Kateh F, Nyenswah TG, Galvani AP: Bolstering Community Cooperation in Ebola Resurgence Protocols: Combining Field Blood Draw and Point-of-Care Diagnosis. PLoS Med. 2017 Jan; 2017 Jan 24. PMID: 28118353

Pandey A, Galvani A: Strategies for Trypanosoma brucei gambiense elimination. Lancet Glob Health. 2017 Jan; 2016 Nov 21. PMID: 27884708

Fitzpatrick MC, Shah HA, Pandey A, Bilinski AM, Kakkar M, Clark AD, Townsend JP, Abbas SS, Galvani AP: One Health approach to cost-effective rabies control in India. Proc Natl Acad Sci U S A. 2016 Dec 20. PMID: 27994161

Galvani AP, Bauch CT, Anand M, Singer BH, Levin SA: Human-environment interactions in population and ecosystem health. Proc Natl Acad Sci U S A. 2016 Dec 20; 2016 Dec 12. PMID: 27956616

Macarayan E, Ndeffo-Mbah M, Beyrer C, Galvani AP: Philippine drug war and impending public health crisis. Lancet. 2016 Dec 10. PMID: 27979404

Schlüter DK, Ndeffo-Mbah ML, Takougang I, Ukety T, Wanji S, Galvani AP, Diggle PJ: Using Community-Level Prevalence of Loa loa Infection to Predict the Proportion of Highly-Infected Individuals: Statistical Modelling to Support Lymphatic Filariasis and Onchocerciasis Elimination Programs. PLoS Negl Trop Dis. 2016 Dec; 2016 Dec 1. PMID: 27906982

Gilbert JA, Shenoi SV, Moll AP, Friedland GH, Paltiel AD, Galvani AP: Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa. PLoS One. 2016; 2016 Dec 1. PMID: 27906986

Bilinski AM, Fitzpatrick MC, Rupprecht CE, Paltiel AD, Galvani AP: Optimal frequency of rabies vaccination campaigns in Sub-Saharan Africa. Proc Biol Sci. 2016 Nov 16. PMID: 27852799

Yamin D, Jones FK, DeVincenzo JP, Gertler S, Kobiler O, Townsend JP, Galvani AP: Vaccination strategies against respiratory syncytial virus. Proc Natl Acad Sci U S A. 2016 Nov 15; 2016 Oct 31. PMID: 27799521

Ndeffo-Mbah ML, Parpia AS, Galvani AP: Mitigating Prenatal Zika Virus Infection in the Americas. Ann Intern Med. 2016 Oct 18; 2016 Jul 26. PMID: 27454076

Fallah MP, Skrip LA, Dahn BT, Nyenswah TG, Flumo H, Glayweon M, Lorseh TL, Kaler SG, Higgs ES, Galvani AP: Pregnancy outcomes in Liberian women who conceived after recovery from Ebola virus disease. Lancet Glob Health. 2016 Oct. PMID: 27633422

Taylor E, Atkins KE, Medlock J, Li M, Chapman GB, Galvani AP: Cross-Cultural Household Influence on Vaccination Decisions. Med Decis Making. 2016 Oct; 2015 Jun 17. PMID: 26085600

Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, Courtney R, McKee M, Amon JJ, Maher L, Hellard M, Beyrer C, Altice FL: Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016 Sep 10; 2016 Jul 14. PMID: 27427453

Skrip LA, Galvani AP: Next Steps for Ebola Vaccination: Deployment in Non-Epidemic, High-Risk Settings. PLoS Negl Trop Dis. 2016 Aug; 2016 Aug 18. PMID: 27537602

Li M, Taylor EG, Atkins KE, Chapman GB, Galvani AP: Stimulating Influenza Vaccination via Prosocial Motives. PLoS One. 2016; 2016 Jul 26. PMID: 27459237

Herrera JL, Srinivasan R, Brownstein JS, Galvani AP, Meyers LA: Disease Surveillance on Complex Social Networks. PLoS Comput Biol. 2016 Jul; 2016 Jul 14. PMID: 27415615

Fitzpatrick MC, Wenzel NS, Scarpino SV, Althouse BM, Atkins KE, Galvani AP, Townsend JP: Cost-effectiveness of next-generation vaccines: The case of pertussis. Vaccine. 2016 Jun 17; 2016 Apr 14. PMID: 27087151

Atkins KE, Fitzpatrick MC, Galvani AP, Townsend JP: Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States. Am J Epidemiol. 2016 Jun 15; 2016 May 13. PMID: 27188951

Alfaro-Murillo JA, Parpia AS, Fitzpatrick MC, Tamagnan JA, Medlock J, Ndeffo-Mbah ML, Fish D, Ávila-Agüero ML, Marín R, Ko AI, Galvani AP: A Cost-Effectiveness Tool for Informing Policies on Zika Virus Control. PLoS Negl Trop Dis. 2016 May; 2016 May 20. PMID: 27205899

Durham DP, Ndeffo-Mbah ML, Skrip LA, Jones FK, Bauch CT, Galvani AP: National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United States. Proc Natl Acad Sci U S A. 2016 May 3; 2016 Apr 18. PMID: 27091978

DeAngelis H, Scarpino SV, Fitzpatrick MC, Galvani AP, Althouse BM: Epidemiological and Economic Effects of Priming With the Whole-Cell Bordetella pertussis Vaccine. JAMA Pediatr. 2016 May 1. PMID: 27018830

Ndeffo-Mbah ML, Durham DP, Skrip LA, Nsoesie EO, Brownstein JS, Fish D, Galvani AP: Evaluating the effectiveness of localized control strategies to curtail chikungunya. Sci Rep. 2016 Apr 5; 2016 Apr 5. PMID: 27045523

Atkins KE, Pandey A, Wenzel NS, Skrip L, Yamin D, Nyenswah TG, Fallah M, Bawo L, Medlock J, Altice FL, Townsend J, Ndeffo-Mbah ML, Galvani AP: Retrospective Analysis of the 2014-2015 Ebola Epidemic in Liberia. Am J Trop Med Hyg. 2016 Apr; 2016 Feb 29. PMID: 26928839

Durham DP, Olsen MA, Dubberke ER, Galvani AP, Townsend JP: Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings. Emerg Infect Dis. 2016 Apr. PMID: 26982504

Gilbert JA, Medlock J, Townsend JP, Aksoy S, Ndeffo Mbah M, Galvani AP: Determinants of Human African Trypanosomiasis Elimination via Paratransgenesis. PLoS Negl Trop Dis. 2016 Mar; 2016 Mar 8. PMID: 26954675

Fallah M, Dahn B, Nyenswah TG, Massaquoi M, Skrip LA, Yamin D, Mbah MN, Joe N, Freeman S, Harris T, Benson Z, Galvani AP: Interrupting Ebola Transmission in Liberia Through Community-Based Initiatives. Ann Intern Med. 2016 Mar 1; 2016 Jan 5. PMID: 26746879

Parpia AS, Ndeffo-Mbah ML, Wenzel NS, Galvani AP: Effects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa. Emerg Infect Dis. 2016 Mar. PMID: 26886846

Eggo RM, Scott JG, Galvani AP, Meyers LA: Respiratory virus transmission dynamics determine timing of asthma exacerbation peaks: Evidence from a population-level model. Proc Natl Acad Sci U S A. 2016 Feb 23; 2016 Feb 8. PMID: 26858436

Durham DP, Skrip LA, Bruce RD, Vilarinho S, Elbasha EH, Galvani AP, Townsend JP: The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States. Clin Infect Dis. 2016 Feb 1; 2015 Nov 30. PMID: 26628566

Ibuka Y, Ohkusa Y, Sugawara T, Chapman GB, Yamin D, Atkins KE, Taniguchi K, Okabe N, Galvani AP: Social contacts, vaccination decisions and influenza in Japan. J Epidemiol Community Health. 2016 Feb; 2015 Sep 30. PMID: 26424846

Alfaro-Murillo JA, Townsend JP, Galvani AP: Optimizing age of cytomegalovirus screening and vaccination to avert congenital disease in the US. Vaccine. 2016 Jan 4; 2015 Nov 27. PMID: 26631416

Yamin D, Atkins KE, Remy V, Galvani AP: Cost-Effectiveness of Rotavirus Vaccination in France-Accounting for Indirect Protection. Value Health. 2016 Sep - Oct; 2016 Jul 15. PMID: 27712709

Fallah MP, Skrip LA, Gertler S, Yamin D, Galvani AP: Quantifying Poverty as a Driver of Ebola Transmission. PLoS Negl Trop Dis. 2015 Dec; 2015 Dec 31. PMID: 26720278

Greenhalgh S, Galvani AP, Medlock J: Disease elimination and re-emergence in differential-equation models. J Theor Biol. 2015 Dec 21; 2015 Oct 22. PMID: 26471072

Hollingsworth TD, Adams ER, Anderson RM, Atkins K, Bartsch S, Basáñez MG, Behrend M, Blok DJ, Chapman LA, Coffeng L, Courtenay O, Crump RE, de Vlas SJ, Dobson A, Dyson L, Farkas H, Galvani AP, Gambhir M, Gurarie D, Irvine MA, Jervis S, Keeling MJ, Kelly-Hope L, King C, Lee BY, Le Rutte EA, Lietman TM, Ndeffo-Mbah M, Medley GF, Michael E, Pandey A, Peterson JK, Pinsent A, Porco TC, Richardus JH, Reimer L, Rock KS, Singh BK, Stolk W, Swaminathan S, Torr SJ, Townsend J, Truscott J, Walker M, Zoueva A, NTD Modelling Consortium.: Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases. Parasit Vectors. 2015 Dec 9; 2015 Dec 9. PMID: 26652272

Wells CR, Galvani AP: Public health impact of disease-behavior dynamics: Comment on "Coupled disease-behavior dynamics on complex networks: A review" by Z. Wang et al. Phys Life Rev. 2015 Dec; 2015 Oct 19. PMID: 26514411

Townsend JP, Skrip LA, Galvani AP: Impact of bed capacity on spatiotemporal shifts in Ebola transmission. Proc Natl Acad Sci U S A. 2015 Nov 17; 2015 Oct 30. PMID: 26518509

Brook CE, Beauclair R, Ngwenya O, Worden L, Ndeffo-Mbah M, Lietman TM, Satpathy SK, Galvani AP, Porco TC: Spatial heterogeneity in projected leprosy trends in India. Parasit Vectors. 2015 Oct 22; 2015 Oct 22. PMID: 26490137

Pandey A, Atkins KE, Bucheton B, Camara M, Aksoy S, Galvani AP, Ndeffo-Mbah ML: Evaluating long-term effectiveness of sleeping sickness control measures in Guinea. Parasit Vectors. 2015 Oct 22; 2015 Oct 22. PMID: 26490037

Gurarie D, Yoon N, Li E, Ndeffo-Mbah M, Durham D, Phillips AE, Aurelio HO, Ferro J, Galvani AP, King CH: Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa. Parasit Vectors. 2015 Oct 22; 2015 Oct 22. PMID: 26489408

Nsoesie EO, Ricketts RP, Brown HE, Fish D, Durham DP, Ndeffo Mbah ML, Christian T, Ahmed S, Marcellin C, Shelly E, Owers K, Wenzel N, Galvani AP, Brownstein JS: Spatial and Temporal Clustering of Chikungunya Virus Transmission in Dominica. PLoS Negl Trop Dis. 2015; 2015 Aug 14. PMID: 26274813

Fallah M, Skrip LA, d'Harcourt E, Galvani AP: Strategies to prevent future Ebola epidemics. Lancet. 2015 Jul 11. PMID: 26194388

Wells C, Yamin D, Ndeffo-Mbah ML, Wenzel N, Gaffney SG, Townsend JP, Meyers LA, Fallah M, Nyenswah TG, Altice FL, Atkins KE, Galvani AP: Correction: Harnessing Case Isolation and Ring Vaccination to Control Ebola. PLoS Negl Trop Dis. 2015 Jun; 2015 Jun 24. PMID: 26107520

Bellan SE, Pulliam JR, Pearson CA, Champredon D, Fox SJ, Skrip L, Galvani AP, Gambhir M, Lopman BA, Porco TC, Meyers LA, Dushoff J: Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. Lancet Infect Dis. 2015 Jun; 2015 Apr 14. PMID: 25886798

Wells C, Yamin D, Ndeffo-Mbah ML, Wenzel N, Gaffney SG, Townsend JP, Meyers LA, Fallah M, Nyenswah TG, Altice FL, Atkins KE, Galvani AP: Harnessing case isolation and ring vaccination to control Ebola. PLoS Negl Trop Dis. 2015 May; 2015 May 29. PMID: 26024528

Yamin D, Gertler S, Ndeffo-Mbah ML, Galvani AP: Effect of Ebola progression in Liberia. Ann Intern Med. 2015 May 19. PMID: 25984855

Gilbert JA, Long EF, Brooks RP, Friedland GH, Moll AP, Townsend JP, Galvani AP, Shenoi SV: Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South Africa. PLoS One. 2015; 2015 May 4. PMID: 25938501

Scarpino SV, Iamarino A, Wells C, Yamin D, Ndeffo-Mbah M, Wenzel NS, Fox SJ, Nyenswah T, Altice FL, Galvani AP, Meyers LA, Townsend JP: Epidemiological and viral genomic sequence analysis of the 2014 ebola outbreak reveals clustered transmission. Clin Infect Dis. 2015 Apr 1; 2014 Dec 15. PMID: 25516185

Gutfraind A, Galvani AP, Meyers LA: Efficacy and optimization of palivizumab injection regimens against respiratory syncytial virus infection. JAMA Pediatr. 2015 Apr. PMID: 25706618

Bellan SE, Dushoff J, Galvani AP, Meyers LA: Reassessment of HIV-1 acute phase infectivity: accounting for heterogeneity and study design with simulated cohorts. PLoS Med. 2015 Mar; 2015 Mar 17. PMID: 25781323

Atkins KE, Wenzel NS, Ndeffo-Mbah M, Altice FL, Townsend JP, Galvani AP: Under-reporting and case fatality estimates for emerging epidemics. BMJ. 2015 Mar 16; 2015 Mar 16. PMID: 25779635

Ndeffo Mbah ML, Parikh S, Galvani AP: Comparing the impact of artemisinin-based combination therapies on malaria transmission in sub-Saharan Africa. Am J Trop Med Hyg. 2015 Mar; 2015 Jan 26. PMID: 25624402

Funk S, Bansal S, Bauch CT, Eames KT, Edmunds WJ, Galvani AP, Klepac P: Nine challenges in incorporating the dynamics of behaviour in infectious diseases models. Epidemics. 2015 Mar; 2014 Sep 28. PMID: 25843377

Greenhalgh S, Ndeffo M, Galvani AP, Parikh S: The epidemiological impact of HIV antiretroviral therapy on malaria in children. AIDS. 2015 Feb 20. PMID: 25486414

Singh B, Huang HC, Morton DP, Johnson GP, Gutfraind A, Galvani AP, Clements B, Meyers LA: Optimizing distribution of pandemic influenza antiviral drugs. Emerg Infect Dis. 2015 Feb. PMID: 25625858

Yamin D, Gertler S, Ndeffo-Mbah ML, Skrip LA, Fallah M, Nyenswah TG, Altice FL, Galvani AP: Effect of Ebola progression on transmission and control in Liberia. Ann Intern Med. 2015 Jan 6. PMID: 25347321

Lewnard JA, Ndeffo Mbah ML, Alfaro-Murillo JA, Altice FL, Bawo L, Nyenswah TG, Galvani AP: Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis. Lancet Infect Dis. 2014 Dec; 2014 Oct 23. PMID: 25455986

Pandey A, Atkins KE, Medlock J, Wenzel N, Townsend JP, Childs JE, Nyenswah TG, Ndeffo-Mbah ML, Galvani AP: Strategies for containing Ebola in West Africa. Science. 2014 Nov 21; 2014 Oct 30. PMID: 25414312

Galvani AP, Ndeffo-Mbah ML, Wenzel N, Childs JE: Ebola vaccination: if not now, when? Ann Intern Med. 2014 Nov 18. PMID: 25141813

Ndeffo Mbah ML, Skrip L, Greenhalgh S, Hotez P, Galvani AP: Impact of Schistosoma mansoni on malaria transmission in Sub-Saharan Africa. PLoS Negl Trop Dis. 2014 Oct; 2014 Oct 16. PMID: 25329403

Yamin D, Balicer RD, Galvani AP: Cost-effectiveness of influenza vaccination in prior pneumonia patients in Israel. Vaccine. 2014 Jul 16; 2014 Jun 12. PMID: 24930716

Ndeffo Mbah ML, Gilbert JA, Galvani AP: Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities. Epidemics. 2014 Jun; 2014 Apr 29. PMID: 24928666

Braithwaite RS, Nucifora KA, Kessler J, Toohey C, Li L, Mentor SM, Uhler LM, Roberts MS, Galvani A, Bryant K: How inexpensive does an alcohol intervention in Kenya need to be in order to deliver favorable value by reducing HIV-related morbidity and mortality? J Acquir Immune Defic Syndr. 2014 Jun 1. PMID: 24828269

Yamin D, Gavious A, Solnik E, Davidovitch N, Balicer RD, Galvani AP, Pliskin JS: An innovative influenza vaccination policy: targeting last season's patients. PLoS Comput Biol. 2014 May; 2014 May 22. PMID: 24851863

Lipsitch M, Galvani AP: Ethical alternatives to experiments with novel potential pandemic pathogens. PLoS Med. 2014 May; 2014 May 20. PMID: 24844931

Talbert-Slagle K, Atkins KE, Yan KK, Khurana E, Gerstein M, Bradley EH, Berg D, Galvani AP, Townsend JP: Cellular superspreaders: an epidemiological perspective on HIV infection inside the body. PLoS Pathog. 2014 May; 2014 May 8. PMID: 24811311

Skene KJ, Paltiel AD, Shim E, Galvani AP: A marginal benefit approach for vaccinating influenza "superspreaders". Med Decis Making. 2014 May. PMID: 24740238

Gilbert JA, Meyers LA, Galvani AP, Townsend JP: Probabilistic uncertainty analysis of epidemiological modeling to guide public health intervention policy. Epidemics. 2014 Mar; 2013 Nov 19. PMID: 24593920

Ndeffo Mbah ML, Durham DP, Medlock J, Galvani AP: Country- and age-specific optimal allocation of dengue vaccines. J Theor Biol. 2014 Feb 7; 2013 Oct 23. PMID: 24161462

Ibuka Y, Li M, Vietri J, Chapman GB, Galvani AP: Free-riding behavior in vaccination decisions: an experimental study. PLoS One. 2014; 2014 Jan 24. PMID: 24475246

Fitzpatrick MC, Hampson K, Cleaveland S, Mzimbiri I, Lankester F, Lembo T, Meyers LA, Paltiel AD, Galvani AP: Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania. Ann Intern Med. 2014 Jan 21. PMID: 24592494

Boni MF, Galvani AP, Wickelgren AL, Malani A: Economic epidemiology of avian influenza on smallholder poultry farms. Theor Popul Biol. 2013 Dec; 2013 Oct 23. PMID: 24161559

Bauch CT, Galvani AP: Epidemiology. Social factors in epidemiology. Science. 2013 Oct 4. PMID: 24092718

Mbah MLN, Poolman EM, Drain PK, Coffee MP, van der Werf MJ, Galvani AP: HIV and Schistosoma haematobium prevalences correlate in sub-Saharan Africa. Trop Med Int Health. 2013 Oct; 2013 Aug 18. PMID: 23952297

Durham DP, Ndeffo Mbah ML, Medlock J, Luz PM, Meyers LA, Paltiel AD, Galvani AP: Dengue dynamics and vaccine cost-effectiveness in Brazil. Vaccine. 2013 Aug 20; 2013 Jun 20. PMID: 23791696

Medlock J, Atkins KE, Thomas DN, Aksoy S, Galvani AP: Evaluating paratransgenesis as a potential control strategy for African trypanosomiasis. PLoS Negl Trop Dis. 2013; 2013 Aug 15. PMID: 23967363

Ndeffo Mbah ML, Poolman EM, Atkins KE, Orenstein EW, Meyers LA, Townsend JP, Galvani AP: Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women. PLoS Negl Trop Dis. 2013; 2013 Aug 1. PMID: 23936578

Aksoy S, Caccone A, Galvani AP, Okedi LM: Glossina fuscipes populations provide insights for human African trypanosomiasis transmission in Uganda. Trends Parasitol. 2013 Aug; 2013 Jul 8. PMID: 23845311

Ndeffo Mbah ML, Medlock J, Meyers LA, Galvani AP, Townsend JP: Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty. Vaccine. 2013 Jun 26; 2013 May 16. PMID: 23684837

Atkins KE, Townsend JP, Medlock J, Galvani AP: Epidemiological mechanisms of genetic resistance to kuru. J R Soc Interface. 2013 Aug 6; 2013 Jun 5. PMID: 23740487

Ndeffo Mbah ML, Kjetland EF, Atkins KE, Poolman EM, Orenstein EW, Meyers LA, Townsend JP, Galvani AP: Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa. Proc Natl Acad Sci U S A. 2013 May 7; 2013 Apr 15. PMID: 23589884

Atkins KE, Shim E, Carroll S, Quilici S, Galvani AP: The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales. Vaccine. 2012 Nov 6; 2012 Sep 21. PMID: 23000223

Shim E, Galvani AP: Distinguishing vaccine efficacy and effectiveness. Vaccine. 2012 Oct 19; 2012 Aug 31. PMID: 22944629

Durham DP, Poolman EM, Ibuka Y, Townsend JP, Galvani AP: Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types. J Infect Dis. 2012 Oct; 2012 Aug 7. PMID: 22872732

Shim E, Chapman GB, Townsend JP, Galvani AP: The influence of altruism on influenza vaccination decisions. J R Soc Interface. 2012 Sep 7; 2012 Apr 11. PMID: 22496100

Araz OM, Galvani A, Meyers LA: Geographic prioritization of distributing pandemic influenza vaccines. Health Care Manag Sci. 2012 Sep; 2012 May 18. PMID: 22618029

Chapman GB, Li M, Vietri J, Ibuka Y, Thomas D, Yoon H, Galvani AP: Using game theory to examine incentives in influenza vaccination behavior. Psychol Sci. 2012 Sep 1; 2012 Jul 18. PMID: 22810166

Tsao K, Fish D, Galvani AP: Predicted outcomes of vaccinating wildlife to reduce human risk of Lyme disease. Vector Borne Zoonotic Dis. 2012 Jul; 2012 Jan 17. PMID: 22251312

Araz OM, Damien P, Paltiel DA, Burke S, van de Geijn B, Galvani A, Meyers LA: Simulating school closure policies for cost effective pandemic decision making. BMC Public Health. 2012 Jun 18; 2012 Jun 18. PMID: 22713694

Hladish T, Melamud E, Barrera LA, Galvani A, Meyers LA: EpiFire: An open source C++ library and application for contact network epidemiology. BMC Bioinformatics. 2012 May 4; 2012 May 4. PMID: 22559915

Ibuka Y, Paltiel AD, Galvani AP: Impact of program scale and indirect effects on the cost-effectiveness of vaccination programs. Med Decis Making. 2012 May-Jun; 2012 Apr 3. PMID: 22472916

Vietri JT, Li M, Galvani AP, Chapman GB: Vaccinating to help ourselves and others. Med Decis Making. 2012 May-Jun; 2011 Nov 29. PMID: 22127841

Simpson JE, Hurtado PJ, Medlock J, Molaei G, Andreadis TG, Galvani AP, Diuk-Wasser MA: Vector host-feeding preferences drive transmission of multi-host pathogens: West Nile virus as a model system. Proc Biol Sci. 2012 Mar 7; 2011 Aug 17. PMID: 21849315

Atkins KE, Shim E, Pitzer VE, Galvani AP: Impact of rotavirus vaccination on epidemiological dynamics in England and Wales. Vaccine. 2012 Jan 11; 2011 Nov 28. PMID: 22133508

Liu J, Kochin BF, Tekle YI, Galvani AP: Epidemiological game-theory dynamics of chickenpox vaccination in the USA and Israel. J R Soc Interface. 2012 Jan 7; 2011 Jun 1. PMID: 21632611

Tully SP, Anonychuk AM, Sanchez DM, Galvani AP, Bauch CT: Time for change? An economic evaluation of integrated cervical screening and HPV immunization programs in Canada. Vaccine. 2012 Jan 5; 2011 Nov 7. PMID: 22075091

Karan A, Chapman GB, Galvani A: The influence of poverty and culture on the transmission of parasitic infections in rural nicaraguan villages. J Parasitol Res. 2012; 2012 Aug 15. PMID: 22934154

Ndeffo Mbah ML, Liu J, Bauch CT, Tekel YI, Medlock J, Meyers LA, Galvani AP: The impact of imitation on vaccination behavior in social contact networks. PLoS Comput Biol. 2012; 2012 Apr 12. PMID: 22511859

Padmanabha H, Durham D, Correa F, Diuk-Wasser M, Galvani A: The interactive roles of Aedes aegypti super-production and human density in dengue transmission. PLoS Negl Trop Dis. 2012; 2012 Aug 28. PMID: 22953017

Fitzpatrick MC, Hampson K, Cleaveland S, Meyers LA, Townsend JP, Galvani AP: Potential for rabies control through dog vaccination in wildlife-abundant communities of Tanzania. PLoS Negl Trop Dis. 2012; 2012 Aug 21. PMID: 22928056

Porco TC, Gao D, Scott JC, Shim E, Enanoria WT, Galvani AP, Lietman TM: When does overuse of antibiotics become a tragedy of the commons? PLoS One. 2012; 2012 Dec 7. PMID: 23236344

Tekle YI, Nielsen KM, Liu J, Pettigrew MM, Meyers LA, Galvani AP, Townsend JP: Controlling antimicrobial resistance through targeted, vaccine-induced replacement of strains. PLoS One. 2012; 2012 Dec 5. PMID: 23227198

Pitzer VE, Atkins KE, de Blasio BF, Van Effelterre T, Atchison CJ, Harris JP, Shim E, Galvani AP, Edmunds WJ, Viboud C, Patel MM, Grenfell BT, Parashar UD, Lopman BA: Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models. PLoS One. 2012; 2012 Aug 13. PMID: 22912699

Li M, Chapman GB, Ibuka Y, Meyers LA, Galvani A: Who got vaccinated against H1N1 pandemic influenza? A longitudinal study in four U.S. cities. Psychol Health. 2012; 2011 Jul 7. PMID: 21736427

Alam U, Medlock J, Brelsfoard C, Pais R, Lohs C, Balmand S, Carnogursky J, Heddi A, Takac P, Galvani A, Aksoy S: Wolbachia symbiont infections induce strong cytoplasmic incompatibility in the tsetse fly Glossina morsitans. PLoS Pathog. 2011 Dec; 2011 Dec 8. PMID: 22174680

Wells CR, Tchuenche JM, Meyers LA, Galvani AP, Bauch CT: Impact of imitation processes on the effectiveness of ring vaccination. Bull Math Biol. 2011 Nov; 2011 Mar 16. PMID: 21409511

Volz EM, Miller JC, Galvani A, Ancel Meyers L: Effects of heterogeneous and clustered contact patterns on infectious disease dynamics. PLoS Comput Biol. 2011 Jun; 2011 Jun 2. PMID: 21673864

Luz PM, Vanni T, Medlock J, Paltiel AD, Galvani AP: Dengue vector control strategies in an urban setting: an economic modelling assessment. Lancet. 2011 May 14; 2011 May 3. PMID: 21546076

Vietri JT, Chapman GB, Li M, Galvani AP: Preferences for HPV vaccination in parent-child dyads: Similarities and acknowledged differences. Prev Med. 2011 May; 2011 Mar 23. PMID: 21396952

Reluga TC, Galvani AP: A general approach for population games with application to vaccination. Math Biosci. 2011 Apr; 2011 Jan 28. PMID: 21277314

Davis S, Aksoy S, Galvani A: A global sensitivity analysis for African sleeping sickness. Parasitology. 2011 Apr; 2010 Nov 16. PMID: 21078220

Shim E, Meyers LA, Galvani AP: Optimal H1N1 vaccination strategies based on self-interest versus group interest. BMC Public Health. 2011 Feb 25; 2011 Feb 25. PMID: 21356133

Cornforth DM, Reluga TC, Shim E, Bauch CT, Galvani AP, Meyers LA: Erratic flu vaccination emerges from short-sighted behavior in contact networks. PLoS Comput Biol. 2011 Jan 27; 2011 Jan 27. PMID: 21298083

Luz PM, Struchiner CJ, Galvani AP: Modeling transmission dynamics and control of vector-borne neglected tropical diseases. PLoS Negl Trop Dis. 2010 Oct 26; 2010 Oct 26. PMID: 21049062

Ibuka Y, Chapman GB, Meyers LA, Li M, Galvani AP: The dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza. BMC Infect Dis. 2010 Oct 14; 2010 Oct 14. PMID: 20946662

Shim E, Chapman GB, Galvani AP: Decision making with regard to antiviral intervention during an influenza pandemic. Med Decis Making. 2010 Jul-Aug. PMID: 20634545

Bauch CT, Li M, Chapman G, Galvani AP: Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low? Lancet Infect Dis. 2010 Feb. PMID: 20113982

Li M, Vietri J, Galvani AP, Chapman GB: How do people value life? Psychol Sci. 2010 Feb; 2009 Dec 22. PMID: 20424038

Medlock J, Meyers LA, Galvani A: Optimizing allocation for a delayed influenza vaccination campaign. PLoS Curr. 2009 Dec 9; 2009 Dec 9. PMID: 20033093

Matser A, Hartemink N, Heesterbeek H, Galvani A, Davis S: Elasticity analysis in epidemiology: an application to tick-borne infections. Ecol Lett. 2009 Dec; 2009 Sep 8. PMID: 19740112

Shim E, Hampson K, Cleaveland S, Galvani AP: Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania. Vaccine. 2009 Nov 27. PMID: 19925948

Medlock J, Luz PM, Struchiner CJ, Galvani AP: The impact of transgenic mosquitoes on dengue virulence to humans and mosquitoes. Am Nat. 2009 Oct. PMID: 19737112

Shim E, Kochin B, Galvani A: Insights from epidemiological game theory into gender-specific vaccination against rubella. Math Biosci Eng. 2009 Oct. PMID: 19835431

Medlock J, Galvani AP: Optimizing influenza vaccine distribution. Science. 2009 Sep 25; 2009 Aug 20. PMID: 19696313

Luz PM, Codeço CT, Medlock J, Struchiner CJ, Valle D, Galvani AP: Impact of insecticide interventions on the abundance and resistance profile of Aedes aegypti. Epidemiol Infect. 2009 Aug; 2009 Jan 12. PMID: 19134235

Basu S, Galvani AP: The evolution of tuberculosis virulence. Bull Math Biol. 2009 Jul; 2009 Jan 27. PMID: 19172358

Shim E, Galvani AP: Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination. Vaccine. 2009 Jun 19; 2009 May 3. PMID: 19389452

Basu S, Friedland GH, Medlock J, Andrews JR, Shah NS, Gandhi NR, Moll A, Moodley P, Sturm AW, Galvani AP: Averting epidemics of extensively drug-resistant tuberculosis. Proc Natl Acad Sci U S A. 2009 May 5; 2009 Apr 13. PMID: 19365076

Reluga TC, Medlock J, Galvani A: The discounted reproductive number for epidemiology. Math Biosci Eng. 2009 Apr. PMID: 19364158

Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, Gandhi NR, Galvani AP: Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis. 2009 Mar. PMID: 19246019

Luz PM, Grinsztejn B, Galvani AP: Disability adjusted life years lost to dengue in Brazil. Trop Med Int Health. 2009 Feb; 2009 Jan 20. PMID: 19171013

Shim E, Galvani AP: Evolutionary repercussions of avian culling on host resistance and influenza virulence. PLoS One. 2009; 2009 May 11. PMID: 19430529

Basu S, Chapman GB, Galvani AP: Integrating epidemiology, psychology, and economics to achieve HPV vaccination targets. Proc Natl Acad Sci U S A. 2008 Dec 2; 2008 Nov 17. PMID: 19015536

Luz PM, Mendes BV, Codeço CT, Struchiner CJ, Galvani AP: Time series analysis of dengue incidence in Rio de Janeiro, Brazil. Am J Trop Med Hyg. 2008 Dec. PMID: 19052308

Basu S, Galvani AP: The transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach. Epidemiol Infect. 2008 Dec; 2008 Jul 7. PMID: 18606028

Basu S, Orenstein E, Galvani AP: The theoretical influence of immunity between strain groups on the progression of drug-resistant tuberculosis epidemics. J Infect Dis. 2008 Nov 15. PMID: 18816192

Poolman EM, Elbasha EH, Galvani AP: Vaccination and the evolutionary ecology of human papillomavirus. Vaccine. 2008 Jul 18. PMID: 18773535

Day T, Galvani A, Struchiner C, Gumel A: The evolutionary consequences of vaccination. Vaccine. 2008 Jul 18. PMID: 18773533

Hu C, Rio RV, Medlock J, Haines LR, Nayduch D, Savage AF, Guz N, Attardo GM, Pearson TW, Galvani AP, Aksoy S: Infections with immunogenic trypanosomes reduce tsetse reproductive fitness: potential impact of different parasite strains on vector population structure. PLoS Negl Trop Dis. 2008 Mar 12; 2008 Mar 12. PMID: 18335067

Codeço CT, Luz PM, Coelho F, Galvani AP, Struchiner C: Vaccinating in disease-free regions: a vaccine model with application to yellow fever. J R Soc Interface. 2007 Dec 22. PMID: 17442650

Reluga TC, Medlock J, Poolman E, Galvani AP: Optimal timing of disease transmission in an age-structured population. Bull Math Biol. 2007 Nov; 2007 Aug 15. PMID: 17701261

Reluga T, Meza R, Walton DB, Galvani AP: Reservoir interactions and disease emergence. Theor Popul Biol. 2007 Nov; 2007 Jul 25. PMID: 17719617

Basu S, Andrews JR, Poolman EM, Gandhi NR, Shah NS, Moll A, Moodley P, Galvani AP, Friedland GH: Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet. 2007 Oct 27. PMID: 17964351

Basu S, Galvani AP: Re: "Multiparameter calibration of a natural history model of cervical cancer". Am J Epidemiol. 2007 Oct 15; 2007 Aug 29. PMID: 17728268

Galvani AP, Reluga TC, Chapman GB: Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proc Natl Acad Sci U S A. 2007 Mar 27; 2007 Mar 16. PMID: 17369367

Poolman EM, Galvani AP: Evaluating candidate agents of selective pressure for cystic fibrosis. J R Soc Interface. 2007 Feb 22. PMID: 17015291

Rainer TH, Lee N, Ip M, Galvani AP, Antonio GE, Wong KT, Chan DP, Ng AW, Shing KK, Chau SS, Mak P, Chan PK, Ahuja AT, Hui DS, Sung JJ: Features discriminating SARS from other severe viral respiratory tract infections. Eur J Clin Microbiol Infect Dis. 2007 Feb. PMID: 17219094

Basu S, Galvani AP: Extensively drug-resistant tuberculosis in South Africa. Lancet. 2007 Jan 27. PMID: 17258662

Reluga TC, Bauch CT, Galvani AP: Evolving public perceptions and stability in vaccine uptake. Math Biosci. 2006 Dec; 2006 Aug 26. PMID: 17056073

Poolman EM, Galvani AP: Modeling targeted ivermectin treatment for controlling river blindness. Am J Trop Med Hyg. 2006 Nov. PMID: 17123988

Galvani AP, Medlock J, Chapman GB: The ethics of influenza vaccination. Science. 2006 Aug 11. PMID: 16906649

Reluga TC, Medlock J, Galvani AP: A model of spatial epidemic spread when individuals move within overlapping home ranges. Bull Math Biol. 2006 Feb; 2006 Apr 4. PMID: 16794937

Galvani AP, May RM: Epidemiology: dimensions of superspreading. Nature. 2005 Nov 17. PMID: 16292292

Bauch CT, Lloyd-Smith JO, Coffee MP, Galvani AP: Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology. 2005 Nov. PMID: 16222170

Novembre J, Galvani AP, Slatkin M: The geographic spread of the CCR5 Delta32 HIV-resistance allele. PLoS Biol. 2005 Nov; 2005 Oct 18. PMID: 16216086

Galvani AP: The role of mutation accumulation in HIV progression. Proc Biol Sci. 2005 Sep 7. PMID: 16096099

Elbasha EH, Galvani AP: Vaccination against multiple HPV types. Math Biosci. 2005 Sep. PMID: 16095627

Porco TC, Lloyd-Smith JO, Gross KL, Galvani AP: The effect of treatment on pathogen virulence. J Theor Biol. 2005 Mar 7; 2004 Nov 13. PMID: 15615623

Galvani AP: Age-dependent epidemiological patterns and strain diversity in helminth parasites. J Parasitol. 2005 Feb. PMID: 15856867

Galvani AP, Novembre J: The evolutionary history of the CCR5-Delta32 HIV-resistance mutation. Microbes Infect. 2005 Feb; 2005 Jan 8. PMID: 15715976

Galvani AP: Emerging infections: what have we learned from SARS? Emerg Infect Dis. 2004 Jul. PMID: 15338569

Galvani AP, Slatkin M: Intense selection in an age-structured population. Proc Biol Sci. 2004 Jan 22. PMID: 15058394

Galvani AP, Slatkin M: Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele. Proc Natl Acad Sci U S A. 2003 Dec 9; 2003 Nov 25. PMID: 14645720

Lloyd-Smith JO, Galvani AP, Getz WM: Curtailing transmission of severe acute respiratory syndrome within a community and its hospital. Proc Biol Sci. 2003 Oct 7. PMID: 14561285

Bauch CT, Galvani AP, Earn DJ: Group interest versus self-interest in smallpox vaccination policy. Proc Natl Acad Sci U S A. 2003 Sep 2; 2003 Aug 14. PMID: 12920181

Galvani AP, Lei X, Jewell NP: Severe acute respiratory syndrome: temporal stability and geographic variation in case-fatality rates and doubling times. Emerg Infect Dis. 2003 Aug. PMID: 12967499

Bauch CT, Galvani AP: Using network models to approximate spatial point-process models. Math Biosci. 2003 Jul. PMID: 12788235

Galvani AP: Immunity, antigenic heterogeneity, and aggregation of helminth parasites. J Parasitol. 2003 Apr. PMID: 12760634

Ferguson NM, Galvani AP, Bush RM: Ecological and immunological determinants of influenza evolution. Nature. 2003 Mar 27. PMID: 12660783

Galvani AP, Coleman RM, Ferguson NM: The maintenance of sex in parasites. Proc Biol Sci. 2003 Jan 7. PMID: 12590767

Roletto F, Galvani AP, Cristiani C, Valsasina B, Landonio A, Bertolero F: Basic fibroblast growth factor stimulates hepatocyte growth factor/scatter factor secretion by human mesenchymal cells. J Cell Physiol. 1996 Jan. PMID: 8557758

Galvani AP, Cristiani C, Carpinelli P, Landonio A, Bertolero F: Suramin modulates cellular levels of hepatocyte growth factor receptor by inducing shedding of a soluble form. Biochem Pharmacol. 1995 Sep 28. PMID: 7575680

Galvani AP, Zamai M, Nitti GP, Curatolo L, Ciavolella A, Caiolfa VR: Big endothelin-converting enzyme activities in subcellular fractions of bovine aortic endothelial cells. J Cardiovasc Pharmacol. 1991. PMID: 1725415